Researchers identified several lncRNAs linked to ovarian cancer, including DNM30S, which correlates with worse survival rates. Targeting these lncRNAs may represent a viable treatment strategy for ovarian cancer.
Researchers have identified a new blood-sugar marker, fructosamine, that can predict patients at highest risk of complications after joint surgery. The test detects changes in glucose control faster than current markers, which could help prevent life-threatening post-surgery complications.
A new meta-analysis reveals that pregnant women with endometriosis are at higher risk for complications such as preterm birth, miscarriage, and small-for-gestational-age infants. The study also shows no association between endometriosis and gestational hypertension or preeclampsia.
A 12-week mindfulness-based parenting intervention improved parenting quality among mothers in medication-assisted treatment for opioid use disorder. Women who experienced high levels of childhood trauma benefited most from attendance, with clinically significant increases in parenting quality.
Researchers at Thomas Jefferson University discovered a novel way phosphorylation affects protein function and localization, leading to increased pain sensitivity. The study offers a new target for developing alternative pain medications and provides a tool for studying synaptic development and pathology.
A new therapy, idarucizumab, has been shown to rapidly reverse the effects of the blood thinner dabigatran in patients with life-threatening bleeding or emergency surgery needs. The study found that idarucizumab was able to stop bleeding within 2.5 hours and allow surgery to begin at a median of 1.6 hours after administration.
Researchers at Thomas Jefferson University discovered a molecule, LRP4, that plays a crucial role in maintaining the balance of excitatory and inhibitory neurons. The molecule is specific to excitatory synapses, suggesting a parallel molecule may exist for inhibitory synapses.
Research in npj Parkinson’s Disease suggests a link between influenza virus infection and the development of Parkinson’s disease. Mice infected with H1N1 influenza were more susceptible to chemical toxins that trigger Parkinson’s symptoms, but vaccination or antiviral medications mitigated this effect.
Researchers at Thomas Jefferson University have discovered a molecule that plays a role in thrombus development but not initial clot formation, offering a new avenue for developing more specific and protective blood thinners. This could reduce the risk of heart attack and stroke without increasing bleeding risk.
A study found that male fruit flies have specific neurons called MS1 that release octopamine to keep them awake during courtship, suppressing sleep. The researchers also discovered that these neurons communicate with other brain cells to enhance male sexual behavior.
A new study found that buprenorphine significantly reduces the duration of therapy for infants with neonatal abstinence syndrome (NAS), cutting treatment time by nearly half. Buprenorphine is a longer-lasting drug than morphine and works differently at the opioid receptor, making it more effective and safer.
A pilot study conducted by Thomas Jefferson University found that a virtual environment education program significantly reduced anxiety and increased comprehension in patients receiving radiation therapy. The program used simulated environments to teach patients about their treatment, resulting in improved confidence and satisfaction.
Researchers at Thomas Jefferson University found significant changes in dopamine and serotonin transporters after a seven-day spiritual retreat, leading to increased positive emotions and self-transcendence. The study suggests that such retreats could prime the brain for spiritual experiences.
A simple fix to avoid unnecessary coronary stents has been discovered, involving the administration of intracoronary nitroglycerin during procedures. By doing so, cardiologists can identify and treat coronary artery spasm, reducing the need for stenting procedures.
A new study by Thomas Jefferson University found that women who received IV fluids at a higher rate during labor were less likely to need a cesarean section and had shorter labors. The study pooled data from seven small clinical trials involving over 1,200 women.
Researchers found that different organs have distinct mitochondrial calcium portal compositions, allowing for tailored energy output. This difference may help explain organ failure and inform disease mechanisms.
Researchers discovered a viral protein that transforms its structure when interacting with DNA, acting like a sensor to measure out appropriate lengths. This finding reveals a potential drug target for human herpesviruses and offers a new therapeutic strategy.
Researchers found that metformin significantly increased tumor cell apoptosis and altered the cancer microenvironment in patients with head and neck cancer. The study suggests that metformin may make cancer more susceptible to standard therapies and has potential immunotherapeutic effects.
The discovery of EphA2 as a receptor for progranulin sheds light on its role in cancer and neurodegenerative diseases. Progranulin binding activates cellular pathways that promote cancer cell aggression, while also triggering a positive feedback loop that increases progranulin secretion.
Researchers at Thomas Jefferson University discovered that a protein called TIGAR promotes the growth of breast cancer cells by altering cell metabolism, which could be targeted with existing drugs like metformin and doxycycline. These therapies have already passed safety testing in humans and may help reduce tumor growth.
Researchers at Thomas Jefferson University have developed a new test to determine immune cell strength, which could help predict patient reactions to various threats. The CaFlux test uses calcium channel detection to assess T-cell responses, offering insights into potential allergies or autoimmunity.
A new meta-analysis suggests that antenatal corticosteroids can improve lung development and reduce severe respiratory distress in preterm babies. The study found a significant reduction in respiratory distress syndrome among babies born between 34-37 weeks, including those delivered via scheduled C-section.
A new study by Thomas Jefferson University shows that community outreach workers may help increase hepatitis B vaccine uptake among Asian Americans, reducing the risk of liver cancer. The program involved lay health workers who provided personalized calls to encourage vaccinations.
Researchers at Thomas Jefferson University found that African American breast cancer survivors face unique challenges, including emotional and physical problems. The study suggests that addressing these issues can help reduce cancer disparities and improve health outcomes.
Researchers at Thomas Jefferson University found alarming rates of obesity and high blood pressure readings among urban student-athletes, similar to the general adolescent population. The study suggests that participation in athletics does not protect against these conditions.
Researchers at Thomas Jefferson University found that cold plasma can promote bone formation by enhancing cell/matrix attachments and increasing focal adhesion kinase activation. The study suggests that the technology could be used to improve bone healing in various medical applications.
A new pilot study evaluates an online decision-support tool called the Decision Counseling Program, which increases rates of active surveillance among men with localized, low-risk prostate cancer. Patients who used the tool reported feeling less conflicted about their treatment decisions.
A meta-analysis of randomized controlled trials found that exercise during pregnancy does not increase the risk of preterm birth and may actually reduce it. Women who exercised were more likely to deliver vaginally and had lower rates of C-sections, gestational diabetes, and high blood pressure.
Scientists have created a tool to track reactive oxygen species (ROS) at the interface of mitochondria and endoplasmic reticulum organelles, revealing localized signaling loops that regulate mitochondrial energy production. ROS play a crucial role in normal biochemical processes, but their effects can be toxic if uncontrolled.
Researchers at Thomas Jefferson University have found a new way to keep the heart pumping, which could lead to new drugs for heart disease. By activating the beta2-adrenergic receptor, they can promote the contraction of heart muscle cells and potentially treat heart failure.
A new study published in CardioRenal Medicine suggests that patients with more inflammation prior to kidney transplantation are at higher risk of developing diabetes after surgery. The researchers also found that a patient's fat stores play a role in this process, and that reducing inflammation before transplant may help prevent diabetes.
A preliminary clinical trial suggests that n-acetylcysteine improves dopamine levels and cognitive function in patients with Parkinson's disease. The study used brain imaging studies to track changes in dopamine levels and found significant improvements in both measures.
A study published in Nutrition & Diabetes has found that overeating reduces levels of the hormone uroguanylin, which signals feelings of fullness in the brain. When mice were overfed, their small intestines stopped producing this hormone, leading to increased eating behavior.
Researchers from Thomas Jefferson University have identified a panel of microRNAs in blood samples that can predict patients at high risk of developing hepatocellular carcinoma, the most common type of liver cancer, in individuals infected with hepatitis B virus.
Researchers found that treating high-risk hospitalized patients for sleep apnea may decrease the frequency of emergency rescues from hospital personnel. Patients who were compliant with positive airway pressure (PAP) treatment had less rapid response events than those who were non-compliant.
A new study reveals that newborns are likely being over-treated for reflux disease, with clinical symptoms only rarely confirmed by the gold-standard reflux test. The study suggests that doctors should use the MII-pH test to confirm diagnoses before treating infants with medications or surgery.
A study published in the American Journal of Cardiology found that nearly half of coronary artery bypass patients are not taking statins and aspirin together, increasing risk of vein graft occlusion. This suggests a lack of coordination between healthcare providers and patients in adhering to long-term prevention measures.
Scientists have identified a mechanism behind pancreatic cancer's resistance to certain drugs and found a way to block it, making the cancer susceptible to formerly ineffective therapies. By targeting a protein called HuR, researchers can revive abandoned drugs and develop more effective combination therapies.
A new study published in the American Journal of Clinical Oncology found that increasing radiation doses for patients with non-metastatic prostate cancer does not improve long-term outcomes. The study analyzed data from 12 randomized controlled trials and found no association between higher doses and improved survival rates.
A study published in the American Journal of Obstetrics and Gynecology found that allowing women to extend labor by four hours instead of three resulted in a significant reduction of cesarean deliveries. The incidence of cesarean delivery was about 19.5 percent in the extended labor group, compared to 43 percent in the usual labor group.
Researchers at Thomas Jefferson University have found that Nit1, a gene previously thought to be a tumor suppressor, actually promotes cancer growth. The study suggests that Nit1 may represent a new target for drug therapy, offering hope for treating aggressive non-small cell lung cancer.
Researchers at Thomas Jefferson University discovered that malfunctioning mitochondria can cause cell death due to excessive calcium uptake, leading to heart attacks and strokes. Inhibiting this calcium overload could provide a novel treatment strategy for these conditions.
Research reveals significant disparities in treatment outcomes for thyroid goiters among older, minority, and male patients. These patients are more likely to develop large, difficult-to-remove goiters that increase the risk of complications and death.
Researchers at Thomas Jefferson University found that combining radiotherapy with the drug panobinostat improved progression-free survival and overall survival for patients with high-grade gliomas. The study, published online ahead of print in the Journal of Neuro-Oncology, offers promise for a new treatment approach.
Researchers at Sidney Kimmel Cancer Center found that Gamma Knife and RapidArc radiation therapy for brain metastases produce similar results, with the latter being faster. This study offers patients a choice of treatments and highlights the importance of advanced radiosurgery technology in treating increasing cases of brain metastases.
A recent study published in the American Journal of Cardiology found that early diagnosis and treatment of sleep apnea may reduce six-month readmissions for patients hospitalized with heart failure. Researchers discovered a significant reduction in hospital visits among patients who used positive airway pressure therapy regularly.
Research at Thomas Jefferson University reveals obesity is associated with a key hormone's absence, leading to tumor suppressor pathway deactivation and increased colorectal cancer risk. A therapeutic approach using the pill linaclotide, structurally related to the lost hormone, may prevent cancer in obese patients.
Researchers have discovered a triple therapy approach that could make treatment-resistant lung cancers susceptible to therapy. The combination of two experimental drugs and radiation therapy was found to be effective in mice with KRAS-related gene mutations.
Researchers at Thomas Jefferson University discovered that both strands of a tiny microRNA are active in suppressing genes in triple negative breast cancer cells. This breakthrough enables the design of specific blockers of one microRNA strand without imitating the opposite strand, opening a pathway to new treatments.
A study at Thomas Jefferson University has successfully increased the production of GM1 ganglioside in mice with Parkinson's disease. The researchers used an enzyme to convert naturally occurring ganglioside molecules into GM1, providing neuronal protection similar to direct GM1 injection.